Patents by Inventor James Nadeau
James Nadeau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11945182Abstract: An assembly (10) for positioning sensors within a tire is provided that has first and second bead sensors (14,16), and first and second side-wall/shoulder sensors (18, 20). A first actuator (30) moves the sensors in a radial direction of the tire, and a second actuator (32) moves the first and second bead sensors in the axial direction of the tire. A third actuator (34) is present and moves the first and second bead sensors in the axial direction relative to the first and second sidewall/shoulder sensors. A fourth actuator (36) moves the first and second bead sensors in the axial direction relative to one another, and a fifth actuator (38) moves the first and second sidewall/shoulder sensors in the axial direction relative to one another.Type: GrantFiled: June 27, 2019Date of Patent: April 2, 2024Assignee: Compagnie Generale des Etablissements MichelinInventors: Christopher Gillis, Michael Hansana, Jonathan Kyle Justice, James Secord, Alexandre Nadeau
-
Patent number: 11938738Abstract: In some examples, an apparatus can include a syringe body including an electrical interface at a side surface of the syringe body, an interface at an end of the syringe body including an output at a distal surface of the syringe body, a print material particles reservoir located in the syringe body, and a structure to adapt a volume of the print material particles reservoir to move print material particles out of the print material particles reservoir through the output, where in response to the volume adapting structure moving from a first position to a second position, a signal is transmitted by the electrical interface.Type: GrantFiled: August 30, 2018Date of Patent: March 26, 2024Assignee: Hewlett-Packard Development Company, L.P.Inventors: Andrew P. Chick, Kenneth K. Smith, Jiwon Moon, Minul Lee, Matthew James Storey, An Tran, Bennett Alexander Nadeau, Zackary Thomas Hickman
-
Patent number: 11292338Abstract: A pedal emulator (20, 100) is provided. The pedal emulator includes an emulator piston (28, 102) coupled to a damper (46, D1) that is contained within a housing (22, 104). The damper is surrounded by first (34, S1) and second (38, S2) springs that are carried by a lower spring seat (114), the lower spring seat being upwardly biased by a third spring (S3), for example a wave spring. The first and second springs and the third spring cooperate to provide a counter-force that is tailored to the desired feel of the pedal. First and second sensors measure travel (72, 74) and force in response to downward compression of the emulator piston, and the damper provides hysteresis upon return travel of the emulator piston.Type: GrantFiled: February 28, 2018Date of Patent: April 5, 2022Assignee: HELLA GmbH & Co. KGaAInventors: Dennis Mark Burke, Kenneth James Nadeau, Werner Austermeier, Henning Irle, Marcus Irrgang
-
Publication number: 20200001711Abstract: A pedal emulator (20, 100) is provided. The pedal emulator includes an emulator piston (28, 102) coupled to a damper (46, D1) that is contained within a housing (22, 104). The damper is surrounded by first (34, S1) and second (38, S2) springs that are carried by a lower spring seat (114), the lower spring seat being upwardly biased by a third spring (S3), for example a wave spring. The first and second springs and the third spring cooperate to provide a counter-force that is tailored to the desired feel of the pedal. First and second sensors measure travel (72,74) and force in response to downward compression of the emulator piston, and the damper provides hysteresis upon return travel of the emulator piston.Type: ApplicationFiled: February 28, 2018Publication date: January 2, 2020Inventors: Dennis Mark Burke, Kenneth James Nadeau, Werner Austermeier, Henning Irle, Marcus Irrgang
-
Patent number: 10113285Abstract: A revetment system includes multiple layers to reinforce a surface exposed to possible high water flow. The revetment system includes both a cellular confinement layer and an articulated block layer. The cellular confinement layer is adapted to be placed on the ground surface to be protected. The block layer is mounted on top of that cellular confinement layer. Optional geosynthetic layers may be mounted under the cellular confinement layer and between the cellular confinement layer and block layers.Type: GrantFiled: September 16, 2016Date of Patent: October 30, 2018Assignee: Shoretec, LLCInventor: James A. Nadeau
-
Publication number: 20170081819Abstract: A revetment system includes multiple layers to reinforce a surface exposed to possible high water flow. The revetment system includes both a cellular confinement layer and an articulated block layer. The cellular confinement layer is adapted to be placed on the ground surface to be protected. The block layer is mounted on top of that cellular confinement layer. Optional geosynthetic layers may be mounted under the cellular confinement layer and between the cellular confinement layer and block layers.Type: ApplicationFiled: September 16, 2016Publication date: March 23, 2017Applicant: Shoretec, LLCInventor: James A. Nadeau
-
Patent number: 8420320Abstract: The present invention relates, in general, to probes, methods, and kits used to determine the presence or absence of a microorganism in a sample. The probes, methods, and kits comprise at least one capture probe and/or at least one detector probe.Type: GrantFiled: December 21, 2009Date of Patent: April 16, 2013Assignee: Becton, Dickinson and CompanyInventors: Tobin J. Hellyer, James Nadeau, Jianrong Lou
-
Patent number: 8372605Abstract: A high-sensitivity, low-background immuno-amplification assay is provided, which offers a streamlined workflow suitable for high-throughput assays of clinically relevant samples, such as blood and other bodily fluids. The assay comprises the use of two proximity members that each comprise an analyte-specific binding component conjugated to an oligonucleotide. Binding an analyte brings the oligonucleotide moieties of the proximity members in sufficiently close contact that the oligonucleotides form an amplicon. The presence of the analyte then is detected through amplification of the amplicon and detection of the amplified nucleic acids. The sensitivity of the assay of the present invention is improved by preventing spurious or non-specific amplicon formation by proximity members that are not complexed with an analyte.Type: GrantFiled: March 25, 2011Date of Patent: February 12, 2013Assignee: Becton, Dickinson and CompanyInventors: James Nadeau, Tobin J. Hellyer, Dolores M. Berger, William Nussbaumer, Robert Rosenstein, Andrew Kuhn, Sha-Sha Wang, Keith Edward Thornton
-
Publication number: 20110244457Abstract: A high-sensitivity, low-background immuno-amplification assay is provided, which offers a streamlined workflow suitable for high-throughput assays of clinically relevant samples, such as blood and other bodily fluids. The assay comprises the use of two proximity members that each comprise an analyte-specific binding component conjugated to an oligonucleotide. Binding an analyte brings the oligonucleotide moieties of the proximity members in sufficiently close contact that the oligonucleotides form an amplicon. The presence of the analyte then is detected through amplification of the amplicon and detection of the amplified nucleic acids. The sensitivity of the assay of the present invention is improved by preventing spurious or non-specific amplicon formation by proximity members that are not complexed with an analyte.Type: ApplicationFiled: March 25, 2011Publication date: October 6, 2011Applicant: Becton, Dickinson and CompanyInventors: James Nadeau, Tobin Hellyer, Dolores M. Berger, William Nussbaumer, Robert Rosenstein, Andrew Kuhn, Sha Sha Wang, Keith Thornton
-
Patent number: 7932060Abstract: A high-sensitivity, low-background immuno-amplification assay is provided, which offers a streamlined workflow suitable for high-throughput assays of clinically relevant samples, such as blood and other bodily fluids. The assay comprises the use of two proximity members that each comprise an analyte-specific binding component conjugated to an oligonucleotide. Binding an analyte brings the oligonucleotide moieties of the proximity members in sufficiently close contact that the oligonucleotides form an amplicon. The presence of the analyte then is detected through amplification of the amplicon and detection of the amplified nucleic acids. The sensitivity of the assay of the present invention is improved by preventing spurious or non-specific amplicon formation by proximity members that are not complexed with an analyte.Type: GrantFiled: April 19, 2004Date of Patent: April 26, 2011Assignee: Becton, Dickinson and CompanyInventors: James Nadeau, Tobin Hellyer, Dolores Berger, William Nussbaumer, Robert Rosenstein, Andrew Kuhn, Sha Sha Wang, Keith Thornton
-
Publication number: 20100311607Abstract: The present invention relates, in general, to probes, methods, and kits used to determine the presence or absence of a microorganism in a sample. The probes, methods, and kits comprise at least one capture probe and/or at least one detector probe.Type: ApplicationFiled: December 21, 2009Publication date: December 9, 2010Applicant: BECTON, DICKINSON AND COMPANYInventors: Tobin J. Hellyer, James Nadeau, Jianrong Lou
-
Patent number: 7662562Abstract: The present invention relates, in general, to probes, methods, and kits used to determine the presence or absence of a microorganism in a sample. The probes, methods, and kits comprise at least one capture probe and/or at least one detector probe.Type: GrantFiled: August 5, 2005Date of Patent: February 16, 2010Assignee: Becton, Dickinson and CompanyInventors: Tobin J. Hellyer, James Nadeau, Jianrong Lou
-
Publication number: 20080050829Abstract: Mass spectrometry techniques for determining the status of sepsis in an individual are provided. A biomarker profile resolved from a biological sample, taken from the individual, using a mass spectrometry technique is compared to a reference biomarker profile. A single such comparison classifies the individual as belonging to or not belonging to a reference population. The individual's biomarker profile and the reference biomarker profile comprise a plurality of ions each having a mass-to-charge ratio of about 100 Daltons to about 1000 Daltons. The plurality of ions can be detected by electrospray ionization mass spectrometry in positive mode. The comparison uses a decision rule, such as a classification tree, that determines the status of sepsis in the individual without requiring knowledge of the identity of the biomarkers in the biomarker profile from the individual and without requiring knowledge of the identity of the biomarkers in the reference biomarker profile.Type: ApplicationFiled: December 28, 2006Publication date: February 28, 2008Inventors: Richard Ivey, Thomas Gentle, Richard Moore, Michael Towns, Nicholas Bachur, Robert Rosenstein, James Nadeau, Paul Goldenbaum, Song Shi, Donald Copertino, James Garrett, Gregory Tice, Gary Siuzdak, Elizabeth Want, Zhouxin Shen
-
Publication number: 20060127924Abstract: The present invention relates, in general, to probes, methods, and kits used to determine the presence or absence of a microorganism in a sample. The probes, methods, and kits comprise at least one capture probe and/or at least one detector probe.Type: ApplicationFiled: August 5, 2005Publication date: June 15, 2006Applicant: Becton, Dickinson and CompanyInventors: Tobin Hellyer, James Nadeau, Jianrong Lou
-
Publication number: 20050239084Abstract: The invention employs an unlabeled signal primer comprising a 5? adapter sequence for detection of nucleic acid target sequences. The detection system further comprises a reporter probe, the 3? end of which hybridizes to the complement of the 5? adapter sequence of the signal primer to produce a 5? overhang, Polymerase is used to fill in the overhang and synthesize the complement of the 5? overhang of the reporter probe. Synthesis of the reporter probe complement is detected, either directly or indirectly, as an indication of the presence of the target.Type: ApplicationFiled: March 8, 2004Publication date: October 27, 2005Inventors: James Nadeau, Tobin Hellyer
-
Publication number: 20050103746Abstract: An improved method of controlling topographical variations when milling a cross-section of a structure, which can be used to reduce topographical variation on a cross-section of a write-head in order to improve the accuracy of metrology applications. Topographical variation is reduced by using a protective layer that comprises a material having mill rates at higher incidence angles that closely approximate the mill rates of the structure at those higher incidence angles. Topographical variation can be intentionally introduced by using a protective layer that comprises a material having mill rates at higher incidence angles that do not closely approximate the mill rates of the structure at those higher incidence angles.Type: ApplicationFiled: November 18, 2003Publication date: May 19, 2005Inventors: James Nadeau, Pei Zou, Jason Arjavac
-
Publication number: 20050009050Abstract: A high-sensitivity, low-background immuno-amplification assay is provided, which offers a streamlined workflow suitable for high-throughput assays of clinically relevant samples, such as blood and other bodily fluids. The assay comprises the use of two proximity members that each comprise an analyte-specific binding component conjugated to an oligonucleotide. Binding an analyte brings the oligonucleotide moieties of the proximity members in sufficiently close contact that the oligonucleotides form an amplicon. The presence of the analyte then is detected through amplification of the amplicon and detection of the amplified nucleic acids. The sensitivity of the assay of the present invention is improved by preventing spurious or non-specific amplicon formation by proximity members that are not complexed with an analyte. In one embodiment, target-independent amplicon formation is prevented by using hybridization blocker oligonucleotides that bind oligonucleotide moieties that are not hybridized to each other.Type: ApplicationFiled: April 19, 2004Publication date: January 13, 2005Inventors: James Nadeau, Tobin Hellyer, Dolores Berger, William Nussbaumer, Robert Rosenstein, Andrew Kuhn, Sha Wang, Keith Thornton